Nephrogen

Biotechnology Research

New York, New York 431 followers

Curative gene therapies for kidney diseases

View all 5 employees

About us

Nephrogen is a biotech company developing curative gene therapies for kidney diseases. Our initial focus is on polycystic kidney disease (PKD), which affects 600,000 Americans and has no effective treatment or cure.

Website: http://nephrogenbiotech.com
External link for Nephrogen
Industry: Biotechnology Research
Company size: 2-10 employees
Headquarters: New York, New York
Type: Privately Held
Founded: 2015

Locations

Primary

New York, New York 10027, US

Get directions
100 Cummings Center

Suite #451c

Beverly, Massachusetts 01915, US

Get directions

Employees at Nephrogen

See all employees

Updates

Nephrogen

431 followers
1mo Edited
Report this post
We are thrilled to share that we have been selected as a winner in the 2024 Millipore Sigma Biotech Grant Program! Looking forward to working with Sigma to bring out therapies to patients faster. Kudos to Lily Thompson, Fernando Gomez García, Najani Johnson, Vivek Bhalla, and Demetri M. for their hard work!
Naomi Baer

Business Development Consultant, Emerging Biotech at MilliporeSigma
1mo

Please help us congratulate Nephrogen, a resident at Biolabs@NYULangone, for being selected as a finalist in the MilliporeSigma's 2024 Advance Biotech Grant program. Award will be presented on June 12th 2024 Biolabs@NYULangone. Helping Advance Therapeutic Products to Market! Great achievement! 🎉 #Biotech #Innovation #Therapeutics #EmergingBiotech #ProcessDevelopment
1 Comment

Like Comment Share
Nephrogen

431 followers
8mo
Report this post
Nephrogen was delighted to present at the NewYorkBIO Mini Pitch Day last week. It was great to connect with others in the New York Life Sciences Ecosystem, thank you to all the mentors who offered advice on our pitch!
NewYorkBIO

3,895 followers
8mo

Last Thursday, NewYorkBIO hosted the second Mini Pitch Day of the year in collaboration with JLABS @ NYC. Each of the ten presenting companies offered a new approach to therapeutic-focused concepts, highlighting the remarkable innovations found in the NewYorkBIO community. The event was outstanding, largely thanks to the exceptional talents of the companies who presented and the insightful judges who offered valuable feedback and questions. The day concluded with the Science in the City QuickFire Challenge Award Ceremony, which was a wonderful way to celebrate the advancement of the New York life science ecosystem. We are grateful for the generosity and support of our sponsors, Biotechnology Innovation Organization and New York City Economic Development Corporation, and our host JLABS @ NYC. NYBIO Team: Jennifer Hawks Bland, Mary Bartlett, Erica Olsen, Alexis Madara JLABS Team: Tingting Zhang-Kharas, PhD Jesse Hwang, Tatiana Canessa Judges: Tingting Zhang-Kharas, PhD, Arthur Tinkelenberg, Anita Riyat, Jesse Hwang, Silvia Garcia Codony, Shannon Plumstead, Gill Sawhney Presenting Companies: Synthis Therapeutics, Inc. Dori Thomas-Karyat; AvantGuard, Inc. Ted Eveleth; Lime Therapeutics Shardule Shah, PhD, MBA; JelikaLite Katya Sverdlov, CFA, Esq.; Nephrogen Demetri M.; DirectSeq Biosciences Shenglong ZHANG; GenKardia David C. Zebrowski, Ph.D.; Orange Therapeutics REBECCA FRANKEL; Neuralina Therapeutics Michael Coyle; Innovene Therapeutics Mario Castellanos, MD.
Like Comment Share
Nephrogen

431 followers
8mo
Report this post
Beyond grateful to share that Nephrogen was selected as the overall winner of the Alnylam Pharmaceuticals $100K Bioventure Challenge and recipient of the John Maraganore Science Entrepreneurship Award! It is an honor to be recognized by Alnylam for our work in developing a new class of medicines for kidney disease patients and to interact with John, a true visionary in the biotech world. If you'd like to join us in our vision of developing the first curative drugs for kidney disease as either a scientist or investor (or just want say hello), drop us a line at info [at] nephrogenbiotech.com!

Nephrogen

nephrogenbiotech.com

1 Comment

Like Comment Share

Browse jobs

Funding

Nephrogen 1 total round

Last Round

Non equity assistance Oct 1, 2020

See more info on crunchbase

Nephrogen

Biotechnology Research

New York, New York 431 followers

Curative gene therapies for kidney diseases

About us

Locations

Employees at Nephrogen

Shelley Amster

3Daughters | Chief Strategy & Growth Officer | Co-Founder

Fernando Gomez García

PhD Student in Molecular Medicine

Lily Thompson

Research Scientist @ Nephrogen | Biomolecular Science Senior @ New York University

Najani Johnson

Electrical and Computer Engineer | Undergraduate at University at Albany

Updates

Join now to see what you are missing

Similar pages

Cloverleaf Bio

Waypoint Bio

Orion Therapeutics, Inc.

VenoStent, Inc.

Volumetric

Starling (YC W22)

Biolabs@NYULangone

Trestle Biotherapeutics

Alnylam Pharmaceuticals

Proton Intelligence

Browse jobs

Vice President jobs

Director of Quality jobs

Pilot jobs

Plant Manager jobs

User Experience Specialist jobs

Unity Developer jobs

Director jobs

Manager jobs

Software Engineer jobs

Developer jobs

Dotnet Developer jobs

Head jobs

Chemist jobs

Funding